FIRST HEART VALVE REPLACEMENT USING NEW ROBOTIC SURGERY TECH AND ARTIFICIAL VALVE DESIGNED BY CORCYM

Corcym’s Heart Valve Combined with Tech Developed By CardioPrecision

BOSTON, Aug. 4, 2025 /PRNewswire/ — Corcym today announced that its Perceval Plus^® sutureless aortic heart valve was used in a First-Ever robotic aortic valve replacement, through a tiny incision in the neck of a patient by Marijan Koprivanac, MD, surgeon at Cleveland Clinic’s Heart, Vascular & Thoracic Institute. The procedure represented an important milestone in surgical heart valve replacement.

This achievement shows the many benefits of integrating Corcym’s artificial heart valve with CardioPrecision’s CoreVista® Robot Enabling Platform^®, in what surgeons know as an AVATAR (Advanced Videoscopic Aortic valve surgery by Transcervical Approach using Robot assistance) procedure.

“This pioneering surgical procedure strengthens our foothold in robotic surgery,” said Christian Mazzi, CEO of Corcym. “By having our sutureless valve technology be used in this way, we helped create a new option for robotic cardiac surgery.”

“Combining the artificial heart valve with this new surgical technology means patients should experience less pain and time in the hospital following heart surgery, “said Marijan Koprivanac, M.D. cardiovascular surgeon at Cleveland Clinic. “In fact, we believe that this may be one of the least invasive surgical heart valve replacement options now available.”

“Robotic-assisted surgery is widely practiced across almost every other surgical specialty,” said Fraser Sutherland, MD, CardioPrecision’s Chief Medical Officer. “Now cardiac surgeons can offer patients this least invasive option using robotics with our innovative CoreVista® platform, while ensuring their safety remains paramount.”

About CardioPrecision Ltd
CardioPrecision Ltd, based in Glasgow, UK is the global leader in transcervical access for the treatment of structural heart disease and cardiothoracic interventions.  CardioPrecision is dedicated to making patients’ lives better through the development of innovative, less invasive access solutions for cardiothoracic surgery and cardiovascular interventions. For more information, visit: https://www.cardioprecision.com

About Corcym
Corcym is the only global medical device company dedicated to cardiac surgeons, providing the best solutions to help their patients fight structural heart disease. Founded on five decades of trusted partnerships with cardiac surgeons and a comprehensive portfolio of structural heart solutions. Corcym’s innovative technologies offer surgeons a wide range of repair and replacement options for both open-heart and minimally invasive cardiac surgery techniques. For more information, visit: https://www.corcym.com/

This news release includes forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding expected product benefits, anticipated product approvals, future plans related to the product lines, the benefits of the transaction, including future financial and operating results, objectives and expectations and other statements that are not historical facts. Such statements are based on the views and assumptions of the management of the company and are subject to significant risks and uncertainties.  

Actual future events or results may differ materially from these statements as a result of various factors, including: unexpected costs of device development and approvals, unanticipated outcomes after more expanded pre-clinical and clinical experience with the devices, unexpected changes or delays related to product supply, potentials for unexpected regulatory or quality delays or developments, competitive dynamics, global economic conditions and customer acceptance, and other economic, business, and/or competitive factors. The forward-looking statements speak only as of the date of this communication. Except as required by law, The Company undertakes no obligation to update these statements.

CoreVista is a trademark of CardioPrecision Ltd. Perceval Plus is a trademark of Corcym.

View original content:https://www.prnewswire.com/news-releases/first-heart-valve-replacement-using-new-robotic-surgery-tech-and-artificial-valve-designed-by-corcym-302520690.html

SOURCE Corcym